This biotech with as much cash as market cap and NIH funded trials (small cash burn) is on tape giving presentations at a cell symposium showing therapeutic benefits of its lead drug Bryostatin. Again, if the 4Q read works this is $500 stock. Have to own something or would be biggest miss of a lifetime.
Rob’s Educated Guesses